These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38086156)

  • 1. Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.
    Lawlor MW; Schoser B; Margeta M; Sewry CA; Jones KA; Shieh PB; Kuntz NL; Smith BK; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Blaschek A; Neuhaus S; Foley AR; Saade DN; Tsuchiya E; Qasim UR; Beatka M; Prom MJ; Ott E; Danielson S; Krakau P; Kumar SN; Meng H; Vanden Avond M; Wells C; Gordish-Dressman H; Beggs AH; Christensen S; Conner E; James ES; Lee J; Sadhu C; Miller W; Sepulveda B; Varfaj F; Prasad S; Rico S
    EBioMedicine; 2024 Jan; 99():104894. PubMed ID: 38086156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial.
    Shieh PB; Kuntz NL; Dowling JJ; Müller-Felber W; Bönnemann CG; Seferian AM; Servais L; Smith BK; Muntoni F; Blaschek A; Foley AR; Saade DN; Neuhaus S; Alfano LN; Beggs AH; Buj-Bello A; Childers MK; Duong T; Graham RJ; Jain M; Coats J; MacBean V; James ES; Lee J; Mavilio F; Miller W; Varfaj F; Murtagh M; Han C; Noursalehi M; Lawlor MW; Prasad S; Rico S
    Lancet Neurol; 2023 Dec; 22(12):1125-1139. PubMed ID: 37977713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput transcriptome analyses from ASPIRO, a phase 1/2/3 study of gene replacement therapy for X-linked myotubular myopathy.
    Andreoletti G; Romano O; Chou HJ; Sefid-Dashti MJ; Grilli A; Chen C; Lakshman N; Purushothaman P; Varfaj F; Mavilio F; Bicciato S; Urbinati F
    Am J Hum Genet; 2023 Oct; 110(10):1648-1660. PubMed ID: 37673065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience.
    Graham RJ; Amin R; Demirel N; Edel L; Lilien C; MacBean V; Rafferty GF; Sawnani H; Schön C; Smith BK; Syed F; Sarazen M; Prasad S; Rico S; Perez GF
    Respir Res; 2024 Sep; 25(1):342. PubMed ID: 39285418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
    Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
    Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance.
    Duong T; Harding G; Mannix S; Abel C; Phillips D; Alfano LN; Bönnemann CG; Lilien C; Lowes LP; Servais L; Warken-Madelung B; Nieto Bergman S; James ES; Noursalehi M; Prasad S; Rico S; Bilder DA
    J Neuromuscul Dis; 2021; 8(1):63-77. PubMed ID: 32925083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and health resource use in patients with X-linked myotubular myopathy: insights from US commercial claims.
    Sacks NC; Healey BE; Cyr PL; Slocomb T; James E; Beggs AH; Graham RJ
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1019-1026. PubMed ID: 33843254
    [No Abstract]   [Full Text] [Related]  

  • 8. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of systemic gene therapy in a canine model of myotubular myopathy.
    Elverman M; Goddard MA; Mack D; Snyder JM; Lawlor MW; Meng H; Beggs AH; Buj-Bello A; Poulard K; Marsh AP; Grange RW; Kelly VE; Childers MK
    Muscle Nerve; 2017 Nov; 56(5):943-953. PubMed ID: 28370029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
    Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy.
    Childers MK; Joubert R; Poulard K; Moal C; Grange RW; Doering JA; Lawlor MW; Rider BE; Jamet T; Danièle N; Martin S; Rivière C; Soker T; Hammer C; Van Wittenberghe L; Lockard M; Guan X; Goddard M; Mitchell E; Barber J; Williams JK; Mack DL; Furth ME; Vignaud A; Masurier C; Mavilio F; Moullier P; Beggs AH; Buj-Bello A
    Sci Transl Med; 2014 Jan; 6(220):220ra10. PubMed ID: 24452262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
    Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
    Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species Comparisons.
    Lawlor MW; Beggs AH; Buj-Bello A; Childers MK; Dowling JJ; James ES; Meng H; Moore SA; Prasad S; Schoser B; Sewry CA
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):102-10. PubMed ID: 26823526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an MTM1-mutant iPSC line (CRICKi008-A) from an individual with X-linked myotubular myopathy (XLMTM).
    Devito LG; Lionello VM; Muntoni F; Tedesco FS; Healy L
    Stem Cell Res; 2023 Jun; 69():103079. PubMed ID: 36989620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
    Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
    Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotype of X-linked myotubular myopathy in Labrador Retriever puppies.
    Snead EC; Taylor SM; van der Kooij M; Cosford K; Beggs AH; Shelton GD
    J Vet Intern Med; 2015 Jan; 29(1):254-60. PubMed ID: 25581576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias in patients with X-linked myotubular myopathy.
    Pons-Espinal M; Clotet-Caba J; Cesar-Díaz S; Yubero-Siles D
    Rev Neurol; 2023 Aug; 77(3):79-81. PubMed ID: 37466134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement therapy rescues weakness and improves muscle pathology in mice with X-linked myotubular myopathy.
    Lawlor MW; Armstrong D; Viola MG; Widrick JJ; Meng H; Grange RW; Childers MK; Hsu CP; O'Callaghan M; Pierson CR; Buj-Bello A; Beggs AH
    Hum Mol Genet; 2013 Apr; 22(8):1525-38. PubMed ID: 23307925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.
    Dowling JJ; Müller-Felber W; Smith BK; Bönnemann CG; Kuntz NL; Muntoni F; Servais L; Alfano LN; Beggs AH; Bilder DA; Blaschek A; Duong T; Graham RJ; Jain M; Lawlor MW; Lee J; Coats J; Lilien C; Lowes LP; MacBean V; Neuhaus S; Noursalehi M; Pitts T; Finlay C; Christensen S; Rafferty G; Seferian AM; Tsuchiya E; James ES; Miller W; Sepulveda B; Vila MC; Prasad S; Rico S; Shieh PB;
    J Neuromuscul Dis; 2022; 9(4):503-516. PubMed ID: 35694931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.